Nustendi 180 mg / 10 mg, Filmtabletten

7680675860029 CH-67586 Filmtabletten
Nustendi 180 mg / 10 mg, Filmtabletten
Nustendi 180 mg / 10 mg, Filmtabletten
Nustendi 180 mg / 10 mg, Filmtabletten
1 / 3
google

Article details

Package size
98
Selling units
98
Measure
mg
Galenic form
Filmtabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
15/11/2025
Patient information leaflet
Français
15/11/2025
Patient information leaflet
Italien
15/11/2025
Summary of Product Characteristics
Allemand
15/11/2025
Summary of Product Characteristics
Français
15/11/2025
Summary of Product Characteristics
Italien
15/11/2025

Detailed composition

Substance Quantity Type Category
ezetimibum
10.0 MG Substance Wirkstoff (Principe actif)
acidum bempedoicum
180.0 MG Substance Wirkstoff (Principe actif)
lactosum monohydricum
75.0 MG Substance HBESI
cellulosum microcristallinum
- Substance HNIDK
carboxymethylamylum natricum
- Substance HNIDK
povidonum K 30
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
silica colloidalis anhydrica
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK
E 132
- Substance FIMDK
glyceroli monocaprylocapras
- Substance HNIDK
natrii laurilsulfas
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 133
- Substance FIMDK
natrium
1.38 MG Substance HBESI

Reimbursement information

Public price
CHF 240.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2022

Authorization holder

Daiichi Sankyo (Schweiz) AG

8048 Zürich

Authorization information

Swissmedic authorization number
67586
Drug name
Nustendi, Filmtabletten
Galenic form
FILM
ATC Code
C10BA10
Authorization status
Z
Dispensing category
B
First authorization
15/12/2020
Authorization expiration date
31/12/9999
IT Number
07.12.0.
Domain
Human medicine
Field of application
Primäre Hypercholesterinämie (heterozygot familiär und nicht familiär) oder gemischte Dyslipidämie sowie Reduktion des kardiovaskulären Risikos.

Package details

Description (FR)
NUSTENDI cpr pell 180/10 mg 98 pce
Description (DE)
NUSTENDI Filmtabl 180/10 mg 98 Stk
Market launch
15/12/2020
Narcotic (BTM)
No

Other package sizes (1)

NUSTENDI cpr pell 180/10 mg 28 pce
28 MG
GTIN: 7680675860012
View
Buy us a coffee Explore the data